Citotoksičnost legure titana obložene hidroksiapatitom pomoću mlaza plazme
Sažetak
Uvod/Cilj. Oblaganje površine legura titana (Ti) hidroksiapatitom (HAP) poboljšava bioaktivnost i oseointegraciju Ti legura, koje se široko koriste kao implantacioni materijali u stomatologiji i ortopediji. Međutim, stabilnost HAP prevlake i biokompatibilnost takvih legura zavise od primenjene tehnike oblaganja. Cilj ovog rada je bio da se ispita citotoksičnost Ti6Al4V legure obložene sa HAP pomoću plazme korišćenjem originalne metode. Metode. Uzorci Ti6Al4V legure u obliku diska, prečnika 10 mm, debljine 2 mm su presvučeni sa HAP (jednostrano ili obostrano) mlazom atmosferske plazme. Citotoksičnost neobložene i HAP-om obloženih Ti6Al4V legura je ispitivana na osnovu morfoloških karakteristika i vijabilnosti L929 fibroblasta u direktnom kontaktu ćelija sa test materijalima. Odgovarajuća negativna kontrola (polistirenski diskovi) i pozitivna kontrola (diskovi od nikla) istih veličina kao i diskovi Ti6Al4V legura su takođe uključeni u eksperimente. Indirektna citotoksičnost je procenjivana nakon kultivisanja L929 ćelija sa kondicioniranim medijumom (CM), koji je predstavljao ekstrakt testiranih uzoraka inkubiranih u kompletnom Roswel Park Memorial Institute (RPMI) 1640 medijumu za ćelijske kulture. Citotoksični efekat CM je procenjivan na osnovu stepena metaboličke aktivnosti, nekroze, apoptoze i proliferacije L929 ćelija, korišćenjem adekvatnih testova. Rezultati. Neobložena Ti6Al4V legura i Ti6Al4V legura obložena jednostrano sa HAP su okarakterisane kao necitotoksične na osnovu ISO 10993-5 kriterijuma, dok je Ti6Al4V legura obložena sa HAP obostrano pokazivala blagu do umerenu citotoksičnost. Citotoksičnost, koja se manifestovala smanjenjem metaboličke aktivnosti i proliferacije L929 ćelija kao i indukcijom njihove apoptoze i nekroze, je bila značajno smanjena ako su uzorci HAP-om presvučenih legura kondicionirani u medijumu u toku 24 časa. Citotoksičnost CM pripremljenih od Ti6Al4V legura obloženih sa HAP je bila samo delimično smanjena u prisustvu nifelata, blokatora kalcijumovih (Ca) kanala, što ukazuje da Ca joni nisu jedini citotoksični faktor. Zaključak. Originalna metoda oblaganja Ti6Al4V legure sa HAP pomoću atmosferske plazme u obliku spreja visoke energije omogućava stabilnu adheziju prevlake. Citotoksičnost ovako obrađene legure, koja zavisi od količine nanetog HAP, se može znatno smanjiti do necitotoksičnog nivoa prethodnim kondicioniranjem u medijumu. Ova procedura, kojom se uklanjaju rastvorljive toksične komponente, može biti korisna pre in vivo implantacije legura obloženih sa HAP.
Reference
Okazaki Y, Rao S, Ito Y, Tateishi T. Corrosion resistance, me-chanical properties, corrosion fatigue strength and cytocom-patibility of new Ti alloys without Al and V. Biomaterials 1998; 19(13): 1197‒215.
Fojt J, Joska L, Malek J. Corrosion behaviour of porous Ti–39Nb alloy for biomedical applications. Corr Sci 2013; 71: 78–83.
Geetha M, Singh AK, Asokamani R, Gogia AK. Ti based bio-mate¬rials, the ultimate choice for orthopaedic implants – A review. Prog Mater Sci 2009; 54(3): 397‒425.
Upadhyay D, Panchal MA, Dubey RS, Srivastava VK. Corrosion of alloys used in dentistry: A review. Mater Sci Eng A 2006; 432: 1–11.
Bral A, Mommaerts MY. In vivo biofunctionalization of tita-nium patient-specific implants with nano hydroxyapatite and other nano calcium phosphate coatings: A systematic review. J Craniomaxillofacial Surg 2016; 44(4): 400‒12.
Palanivelu R, Kalainathan S, Kumar AR. Characterization stud-ies on plasma sprayed (AT/HA) bi-layered nano ceramics coating on biomedical commercially pure titanium dental im-plant. Ce¬ram Int 2014; 40: 7745‒51.
Drevet R, Viteaux A, Maurin JC, Benhayoune H. Human os-teoblast-like cells response to pulsed electrodeposited calcium phosphate coatings. RSC Advances 2013; 3(28): 11148‒54.
Urquia Edreira ER, Wolke JG, Al Farraj Aldosari A, Al-Johany SS, Anil S, Jansen JA, et al. Effects of calcium phosphate com-position in sputter coatings on in vitro and in vivo perform-ance. J Biomed Mater Res A 2015; 103(1): 300‒10.
Goodman SB, Yao Z, Keeney M, Yang MF. The future of biologic coatings for orthopaedic implants. Biomaterials 2013; 34(13): 3174‒83.
Zhang BG, Myers DE, Wallace GG, Brandt M, Choong PF. Bio-ac¬tive coatings for orthopaedic implants - Recent trends in de-velopment of implant coatings. Int J Mol Sci 2014; 15(7): 11878–921.
Mohseni E, Zalnezhad E, Bushroa AR. Comparative investiga-tion on the adhesion of hydroxyapatite coating on Ti–6Al–4V im¬plant: A review paper. Int. J Adhes Adhes 2014, 48: 238–57.
Maxian SH, Zawadsk JP, Dunn MG. Mechanical and histologi-cal evaluation of amorphous calcium phosphate and poorly crystallized hydroxyapatite coatings on titanium implants. J Biomed Mater Res 1993; 27(6): 17–28.
Jokanović V, Vilotijević M, Čolović B, Jenko M, Anžel I, Rudolf R. Enhanced adhesion properties, structure and sintering mecha-nism of hydroxyapatite coatings obtained by plasma jet depo-sition. Plasma Chem Plasma Process 2015; 35: 1‒19.
International Standards Organization. ISO10993-5: Biological evaluation of medical devices, part 5. Geneva: ISO; 2009.
Sieuwerts AM, Klijn JG, Peters HA, Foekens JA. The MTT tetra-zolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the as-sessment of growth characteristics, IC50-values and cell sur-vival. Eur J Clin Chem Clin Biochem 1995; 33(11): 813‒23.
Čolić M, Gasić S, Vucević D, Pavicić L, Popović P, Jandrić D et al. Modulatory effect of 7-thia-8-oxoguanosine on proliferation of rat thymocytes in vitro stimulated with concanavalin A. Int J Immunopharmacol. 2000; 22(3): 203‒12.
Hannon P. A brief review of current orthopedic implant device issues: biomechanics and biocompatibility. Biol End Med 2016; 1(1): 1‒2.
Mohseni E, Zalnezhad E, Bushroa AR. Comparative investiga-tion on the adhesion of hydroxyapatite coating on Ti–6Al–4V im¬plant: A review paper. Int J Adhes 2014; 48: 238–57.
Maxian SH, Zawadsk JP, Dunn MG. Mechanical and histologi-cal evaluation of amorphous calcium phosphate and poorly crystallized hydroxyapatite coatings on titanium implants. J Biomed Mater Res 1993; 27(6): 717–28.
Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185(8): 1481‒6.
Li Y, Wong C, Xiong J, Hodgson P, Wen C. Cytotoxicity of tita-nium and titanium alloying elements. J Dent Res 2010; 89(5): 493‒7.
Sidambe AT. Biocompatibility of Advanced Manufactured Ti-ta¬nium Implants—A Review. Materials 2014; 7(12): 8168‒88.
Chandar S, Kotian R, Madhyastha P, Kabekkodu SP, Rao P. In vi-tro evaluation of cytotoxicity and corrosion behavior of com-mercially pure titanium and Ti-6Al-4V alloy for dental im-plants. J Indian Prosthodont Soc 2017; 17(1): 35‒40.
Yuan Y, Liu C, Qian J, Wang J, Zhang Y. Size-mediated cyto-toxic¬ity and apoptosis of hydroxyapatite nanoparticles in hu-man hepatoma HepG2 cells. Biomaterials 2010; 31(4): 730‒40.
Rahman ZU, Shabib I, Haider W. Rahman ZU, Shabib I, Haider W. Surface characterization and cytotoxicity analysis of plasma sprayed coatings on titanium alloys. Mater Sci Eng C Mater Biol Appl 2016; 67: 675‒83.
Radin SR, Ducheyne P. The effect of calcium phosphate ceramic composition and structure on in vitro behaviour. II. Precipita-tion. J Biomed Mater Res 1993; 27(1): 35‒45.
Sun L, Berndt CC, Gross KA, Kucuk A. Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: a review. J Biomed Mater Res 2001; 58(5): 570‒92.
Mozayeni MA, Milani AS, Marvasti LA, Asgary S. Cytotoxicity of calcium enriched mixture cement compared with mineral trioxide aggregate and intermediate restorative material. Aust Endod J 2012; 38(2): 70‒5.
Dianat O, Azadnia S, Mozayeni MA. Toxicity of calcium hy-drox¬ide nanoparticles on murine fibroblast cell line. Iran En-dod J 2015; 10(1): 49‒54.
Zhao X, Ng S, Heng BC, Guo J, Ma L, Tan TT et al. Cytotoxici-ty of hydroxyapatite nanoparticles is shape and cell dependent. Arch Toxicol 2013; 87(6): 1037‒52.
